TOKYO, May 11 (Pulse News Wire) – Teijin Limited (3401.T) reported impairment losses and related company stock sales gains for its fiscal year ending March 31, 2026. In the fourth quarter of fiscal 2026, the company recorded impairment losses of ¥25.40 billion, which were recognized as part of cost of sales and selling, general, and administrative expenses amounting to ¥2.800 billion and ¥22.60 billion, respectively.
Additionally, due to a decline in the value of shares held in Teijin Aramid B.V. (TABV), the company recorded a loss of ¥28.90 billion in individual financial statements. In the first quarter of fiscal 2027, Teijin expects to recognize gains from the sale of shares in DuPont Teijin Advanced Papers Japan Co., Ltd. (DTPJ) and DuPont Teijin Advanced Papers (Asia) Limited (DTPA).
Following the completion of share transfers to DuPont de Nemours, Inc. on April 1, 2026, the company anticipates recording approximately ¥45.50 billion in extraordinary income in consolidated financial statements and around ¥41.90 billion in special income in individual financial statements. The impairment losses for fiscal 2026 have been incorporated into the annual forecast released on March 31, 2026, with no deviation from expectations. Similarly, the anticipated gains from the sale of DTPJ and DTPA shares are reflected in the fiscal 2027 outlook published today, aligning with projected figures.
🟢 Confidence: High AI-translated content.